Retraction Note to: Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR‑181 level.
Cancer Chemother Pharmacol. 2021 May;87(5):721. doi: 10.1007/s00280-020-04166-1.
Cancer Chemother Pharmacol. 2021.
PMID: 33104845
No abstract available.